Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03538288 · ClinicalTrials.gov registry record · NA

Feasibility Trial of rTMS for Cannabis Use Disorder

A NA study of Cannabis, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
3
Enrollment target
1
Study location

NCT03538288 is a NA study of Cannabis that has completed, run by Medical University of South Carolina. The registered enrollment target is 3 participants, below the 111-participant average among 24 other Cannabis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03538288, a NA study of Cannabis, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
3 participants
Enrollment target
1
Study location

Study Summary

This small pilot trial will recruit 10 cannabis use disordered participants and apply 20 sessions of rTMS in conjunction with a two session Brief Marijuana Dependance Counseling treatment paradigm. The investigators are primarily seeking to determine if the proposed paradigm is feasible and well tolerated.

Conditions Studied

Interventions

  • DEVICE rTMS

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2016-10-01
Est. Completion 2017-07-01
Phase NA

What the Registry Record Tells You About NCT03538288

The ClinicalTrials.gov registry entry for NCT03538288 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 111-participant average among 24 other Cannabis trials with a reported enrollment target (97% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.

NCT03538288 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03538288 about?

NCT03538288 is a clinical study titled "Feasibility Trial of rTMS for Cannabis Use Disorder". This small pilot trial will recruit 10 cannabis use disordered participants and apply 20 sessions of rTMS in conjunction with a two session Brief Marijuana Dependance Counseling treatment paradigm. The investigators are primarily seeking to determine if the proposed paradigm is feasible and well tol...

What is the current status of trial NCT03538288?

This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2016-10-01. Estimated completion is 2017-07-01.

What conditions does trial NCT03538288 study?

This clinical trial studies the following conditions: Cannabis.

What interventions are being tested in trial NCT03538288?

The interventions under investigation include: rTMS (DEVICE).

Who is sponsoring clinical trial NCT03538288?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03538288 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cannabis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.